Acurx Pharmaceuticals (ACXP) Net Shares Issued and Repurchased (2020 - 2025)

Acurx Pharmaceuticals (ACXP) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $33775.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 96.23% year-over-year to $33775.0; the trailing twelve-month figure through Dec 2025 stood at $33775.0 (down 96.23% YoY), and the FY2025 full-year result was $33775.0, down 96.23% from the prior year.
• Net Shares Issued and Repurchased declined to $33775.0 in Q4 2025 per ACXP's latest filing, from $675500.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.4 million in Q3 2021 and bottomed at $2500.0 in Q2 2023.
• Historically, Net Shares Issued and Repurchased has averaged $652494.3 across 5 years, with a median of $492500.0 in 2023.
• The sharpest annual moves came in 2021 and 2025: Net Shares Issued and Repurchased surged 8038.57% in 2021, then tumbled 96.23% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.4 million in 2021, then tumbled by 95.33% to $110000.0 in 2022, then surged by 370.45% to $517500.0 in 2023, then jumped by 72.95% to $895000.0 in 2024, then sank by 96.23% to $33775.0 in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $33775.0, $675500.0, and $895000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.